Transcript Document

Medicare & Medicaid EHR
Incentive Program Final Rule
Implementing the American Recovery and
Reinvestment Act of 2009
Presented by:
Kevin R. Burchill, Esq., FACHE
Director
Date:
August 19, 2010
Overview
• American Recovery & Reinvestment Act
(Recovery Act) – February 17, 2009
• Medicare & Medicaid Electronic Health
Record (EHR) Incentive Program Notice of
Proposed Rulemaking (NPRM)
– Display – December 30, 2009
– Publication – January 13, 2010
• Final Rule on Display – July 13, 2010
• Final Rule Published – July 28, 2010
What Did and Did Not Change
Did Change
•
•
•
•
•
•
•
•
MU Criteria
Clinical Quality Measures
Hospital-Based EPs
Medicaid acute care
hospitals
Medicaid patient volume
Removed reporting period
for adopt, implement or
upgrade (Medicaid)
All programs will start in
2011
More clarification throughout
Did Not Change
• Adopted statutory provider
eligibility and payment
requirements
• MU Matrix Goals
• Hospital Definition
• EPs must demonstrate MU
• Clinical Quality Reporting
Timeline
Changes to Provider Eligibility
• Due to recent legislation, hospital-based
EPs are only those who see more than
90% of their patients in a hospital in-patient
or ER setting
• Medicaid included critical access hospitals
in its definition of “acute care hospital”
(but incentive is like other acute care hospitals,
not following the Medicare CAH formula)
Medicaid Patient Volume
• Medicaid EP participation hinges on patient
volume requirements.
• Medicaid patient volume was significantly
clarified
– Expanded definition of “encounter” to include
any encounter for which Medicaid had any
payment liability (e.g. premiums, co-pays,
waivers)
– Allows States to define patient volume as just
encounters or encounters plus patient panel
(managed care), both or propose a new
methodology
Meaningful Use:
Process of Defining
• National Committee on Vital and Health
Statistics (NCVHS) hearings
• HIT Policy Committee (HITPC)
recommendations
• Listening Sessions with providers/organizations
• Public comments on HITPC recommendations
• Comments received from the Department and
the Office of Management and Budget (OMB)
• Revised based on public comments on the
NPRM
Meaningful Use Stage 1:
Health Outcome Priorities*
• Improve quality, safety, efficiency, and
reduce health disparities
• Engage patients and families in their
health care
• Improve care coordination
• Improve population and public health
• Ensure adequate privacy and security
protections for personal health information
*Adapted from National Priorities Partnership. National Priorities and Goals: Aligning Our Efforts
to Transform America’s Healthcare. Washington, DC: National Quality Forum; 2008.
Meaningful Use: Changes from
the NPRM to the Final Rule
NPRM
Final Rule
Meet all MU reporting objectives
Must meet “core set”/can defer 5 from
optional “menu set”
25 measures for EPs/23 measures for
eligible hospitals
25 measures for EPs/24 for eligible
hospitals.
Measure thresholds range from 10% to
80% of patients or orders (most at
higher range)
Measure thresholds range from 10% to
80% of patients or orders (most at lower
to middle range)
Denominators – To calculate the
threshold, some measures required
manual chart review
Denominators – No measures require
manual chart review to calculate
threshold
Administrative transactions (claims and
eligibility) included
Administrative transactions removed
Measures for Patient-Specific Education
Resources and Advanced Directives
discussed but not proposed
Measures for Patient-Specific Education
Resources and Advanced Directives (for
hospitals) included
Meaningful Use: Changes from
the NPRM to the Final Rule (cont’d)
NPRM
Final Rule
States could propose requirements
above/beyond MU floor, but not with
additional EHR functionality
States’ flexibility with Stage 1 MU is
limited to seeking CMS approval to
require 4 public health-related
objectives to be core instead of menu
Core clinical quality measures (CQM) Modified Core CQM and removed
and specialty measure groups for EPs specialty measure groups for EPs
90 CQM total for EPs
44 CQM total for EPs – must report
total of 6
35 CQM total for eligible hospitals and 15 CQM total for eligible hospitals
8 alternate Medicaid CQM
5 CQM overlap with CHIPRA initial
core set
4 CQM overlap with CHIPRA initial
core set
How were MU Core Objectives
Selected?
• Overarching considerations
– Statutory requirements (e.g. e-prescribing, CQM, health
information exchange)
– Foundational objectives (e.g. privacy and security and
those that provide foundational data needed for other
measures, like demographics, medication lists, etc.)
– Patient-centered
• Patient access (e.g. clinical summaries)
• Patient safety (e.g. drug-drug and drug-allergy features)
– Part of providers’ “normal” practice
• Looked at how the objectives aligned
• Feedback received from HIT Policy Committee
and commenter's
Meaningful Use: Applicability
of Objectives and Measures
• Some MU objectives are not applicable to
every provider’s clinical practice, thus they
would not have any eligible patients or
actions for the measure denominator.
• In these cases, the EP, eligible hospital or
CAH would be excluded from having to
meet that measure
– Example: Dentists who do not perform
immunizations; Chiropractors do not e-prescribe
How Were Thresholds Selected
• 80%: Objective part of standard practice
(e.g. maintain active medication list)
• Others: Defined on a case-by-case basis
based on commenter or clearance
feedback
– Example: e-prescribing set at 40% lowered
from 75% to address concerns by commenter's
regarding non-participation by pharmacies and
patient preference
Meaningful Use –
Stage 1 Core Set
Health
Outcomes
Policy
Priority
Improving
quality,
safety,
efficiency,
and reducing
health
disparities
Stage 1 Objective
Stage 1 Measure
Use CPOE for medication orders directly
entered by any licensed healthcare
professional who can enter orders into the
medical record per state, local, and
professional guidelines
More than 30% of unique patients with at least one
medication in their medication list seen by the EP or
admitted to the eligible hospital or CAH have at least
one medication entered using CPOE
Implement drug-drug and drug-allergy
interaction checks
The EP/eligible hospital/CAH has enabled this
functionality for the entire EHR reporting period
EP Only: Generate and transmit
permissible prescriptions electronically
(eRx)
More than 40% of all permissible prescriptions written
by the EP are transmitted electronically using certified
EHR technology
Record demographics: preferred language,
gender, race, ethnicity, date of birth, and
date and preliminary cause of death in the
event of mortality in the eligible hospital or
CAH
More than 50% of all unique patients seen by the EP or
admitted to the eligible hospital or CAH have
demographics as recorded structured data
Maintain up-to-date problem list of current
and active diagnoses
More than 80% of all unique patients seen by the EP
or admitted to the eligible hospital or CAH have
at least one entry or an indication that no
problems are known for the patient recorded
as structured data
Meaningful Use –
Stage 1 Core Set (cont’d)
Health
Outcomes
Policy
Priority
Improving
quality,
safety,
efficiency,
and reducing
health
disparities
Stage 1 Objective
Stage 1 Measure
Maintain active medication list
More than 80% of all unique patents seen by the EP or
admitted to the eligible hospital or CAH have at least one
entry (or an indication that the patient is not currently
prescribed any medication) recorded as structured data
Maintain active medication allergy list
More than 80% of all unique patents seen by the EP or
admitted to the eligible hospital or CAH have at least one
entry (or an indication that the patient has no known
medication allergies) recorded as structured data
Record and chart vital signs: height, weight,
blood pressure, calculate and display BMI,
plot and display growth charts for children 220 years, including BMI
For more than 50% of all unique patients age 2 and over
seen by the EP or admitted to the eligible hospital or CAH,
height, weight, and blood pressure are recorded as
structured data
Record smoking status for patients 13 years
old or older
More than 50% of all unique patients 13 years or older seen
by the EP or admitted to the eligible hospital or CAH have
smoking status recorded as structured data
Implement one clinical decision support rule
and the ability to track compliance with the
rule
Implement one clinical decision support rule
Report clinical quality measures to CMS or
the States
For 2011, provide aggregate numerator, denominator, and
exclusions through attestation; For 2012, electronically
submit clinical quality measures
Meaningful Use –
Stage 1 Core Set (cont’d)
Health
Outcomes
Policy Priority
Stage 1 Objective
Stage 1 Measure
Provide patients with an electronic copy of their
health information (including diagnostic test
results, problem list, medication lists, medication
allergies, discharge summary, procedures), upon
request
More than 50% of all unique patients of the EP,
eligible hospital or CAH who request an electronic
copy of their health information are provided it
within 3 business days
Hospitals Only: Provide patients with an
electronic copy of their discharge instructions at
time of discharge, upon request
More than 50% of all patients who are discharged
from an eligible hospital or CAH who request an
electronic copy of their discharge instructions are
provided it
EPs Only: Provide clinical summaries for each
office visit
Clinical summaries provided to patients for more
than 50% of all office visits within 3 business days
Improve care
coordination
Capability to exchange key clinical information
(ex: problem list, medication list, medication
allergies, diagnostic test results), among
providers of care and patient authorized entities
electronically
Performed at least one test of the certified EHR
technology’s capacity to electronically exchange
key clinical information
Ensure adequate
privacy and
security protections
for personal health
information
Protect electronic health information created or
maintained by certified EHR technology through
the implementation of appropriate technical
capabilities
Conduct or review a security risk analysis per 45
CFR 164.308(a)(1) and implement updates as
necessary and correct identified security
deficiencies as part of the EP’s, eligible hospital’s
or CAH’s risk management process
Engage patients
and families in their
healthcare
Meaningful Use –
Stage 1 Menu Set
Health
Outcomes
Policy
Priority
Improving
quality,
safety,
efficiency,
and reducing
health
disparities
Stage 1 Objective
Stage 1 Measure
Implement drug-formulary checks
The EP/eligible hospital/CAH has enabled this
functionality and has access to at least one internal or
external drug formulary for the entire EHR reporting
period
Hospitals Only: Record advance directives for
patients 65 years old or older
More than 50% of all unique patients 65 years old or
older admitted to the eligible hospital or CAH have an
indication of an advance directive status recorded
Incorporate clinical lab-test results into
certified EHR technology as structured data
More than 40% of all clinical lab test results ordered by
the EP, or an authorized provider of the eligible hospital
or CAH, for patients admitted during the EHR reporting
period whose results are either in a positive/negative or
numerical format are incorporated in certified EHR
technology as structured data
Generate lists of patients by specific
conditions to use for quality improvement,
reduction of disparities, research or outreach
Generate at least one report listing patients of the EP,
eligible hospital or CAH with a specific condition
EPs Only: Send reminders to patients per
patient preference for preventive/follow-up
care
More than 20% of all unique patients 65 years or older or
5 years old or younger were sent an appropriate
reminder during the EHR reporting period
Meaningful Use –
Stage 1 Menu Set (cont’d)
Health
Outcomes
Policy
Priority
Stage 1 Objective
Stage 1 Measure
Engage
patients and
families in
their health
care
EPs Only: Provide patients with timely electronic
access to their health information (including lab
results, problem list, medication lists, medication
allergies) within 4 business days of the
information being available to the EP
More than 10% of all unique patients seen by the EP
are provided timely (available to the patient within 4
business days of being updated in the certified EHR
technology) electronic access to their health
information subject to the EP’s discretion to withhold
certain information
Use certified EHR technology to identify patientspecific education resources and provide those
resources to the patient, if appropriate
More than 10% of all unique patients seen by the EP
or admitted to the eligible hospital or CAH are
provided patient-specific education resources
The EP, eligible hospital or CAH who receives a
patient from another setting of care or provider
of care or believes an encounter is relevant
should perform medication reconciliation
The EP, eligible hospital or CAH performs medication
reconciliation for more than 50% of transitions of care
in which the patient is transitioned into the care of the
EP or admitted to the eligible hospital or CAH
The EP, eligible hospital or CAH who receives a
patient from another setting of care or provider
of care or refers their patient to another provider
of care should provide a summary of care
record for each transition of care or referral
The EP, eligible hospital or CAH who transitions or
refers their patient to another setting of care or
provider of care provides a summary of care record
for more than 50% of transitions of care and referrals
Improve care
coordination
Meaningful Use –
Stage 1 Menu Set (cont’d)
Health
Outcomes
Policy
Priority
Improve
population
and public
health1
Stage 1 Objective
Stage 1 Measure
Capability to submit electronic data to
immunization registries or Immunization
Information Systems and actual
submission in accordance with
applicable law and practice
Performed at least one test of the certified EHR technology’s
capacity to submit electronic data to immunization registries
and follow-up submission if the test is successful (unless none
of the immunization registries to which the EP, eligible hospital
or CAH submits such information have the capacity to receive
such information electronically)
Hospitals Only: Capability to submit
electronic data on reportable (as
required by state or local law) lab results
to public health agencies and actual
submission in accordance with
applicable law and practice
Performed at least one test of certified EHR technology’s
capacity to provide submission of reportable lab results to public
health agencies and follow-up submission if the test is
successful (unless none of the public health agencies to which
the EP, eligible hospital or CAH submits such information have
the capacity to receive such information electronically)
Capability to submit electronic
syndromic surveillance data to public
health agencies and actual submission
in accordance with applicable law and
practice
Performed at least one test of certified EHR technology’s
capacity to provide electronic syndromic surveillance data to
public health agencies and follow-up submission if the test is
successful (unless none of the public health agencies to which
the EP, eligible hospital or CAH submits such information have
the capacity to receive such information electronically)
Future Stages
• Intend to propose 2 additional Stages through
future rulemaking. Future Stages will expand upon
Stage 1 criteria.
• Stage 1 menu set will be transitioned into core set
for Stage 2
• Administrative transactions will be added
• CPOE measurement will go to 60%
• Will reevaluate other measures – possibly higher
thresholds
• Stage 3 will be further defined in next rulemaking
States’ Flexibility to Revise
Meaningful Use
• States can seek CMS prior approval to
require 4 MU objectives be core for their
Medicaid providers:
– Generate lists of patients by specific conditions
for quality improvement, reduction of
disparities, research or outreach (can specify
particular conditions)
– Reporting to immunization registries, reportable
lab results and syndromic surveillance (can
specify for their providers how to test the
data submission and to which specific
destination)
Meaningful Use for EPs who
Work at Multiple Sites
• An EP who works at multiple locations, but
does not have certified EHR technology
available at all of them would:
– Have to have 50% of their total patient
encounters at locations where certified EHR
technology is available
– Would base all meaningful use measures only
on encounters that occurred at locations where
certified EHR technology is available
MU for Hospitals that Qualify for
Both Medicare & Medicaid Payments
• Applies to sub-section (d) and acute care
hospitals
• Attest/Report on Meaningful Use to CMS
for the Medicare EHR Incentive Program
• Will be deemed meaningful users for
Medicaid (even if the State has CMS
approval for the MU flexibility around public
health objectives)
Clinical Quality Measures
(CQM) Overview
• 2011: EPs, eligible hospitals and CAHs
seeking to demonstrate Meaningful Use
are required to submit aggregate CQM
numerator, denominator, and exclusion
data to CMS or the States by attestation.
• 2012: EPs, eligible hospitals and CAHs
seeking to demonstrate Meaningful Use
are required to electronically submit
aggregate CQM numerator, denominator,
and exclusion data to CMS or the States.
CQM: Eligible Professionals
• Core, Alternate Core, and Additional CQM
sets for EPs
– EPs must report on 3 required core CQM. If the
denominator of 1or more of the required core
measures is 0, then EPs are required to report
results for up to 3 alternate core measures
– EPs also must select 3 additional CQM from a set of
38 CQM (other than the core/alternate core
measures)
– In sum, EPs must report on 6 total measures: 3
required core measures (substituting alternate
core measures where necessary) and 3
additional measures
CQM: Core Set for EPs
NQF Measure Number &
Clinical Quality Measure Title
PQRI Implementation Number
NQF 0013
Hypertension: Blood Pressure
Measurement
NQF 0028
Preventive Care and Screening
Measure Pair: a) Tobacco Use
Assessment b) Tobacco Cessation
Intervention
NQF 0421
PQRI 128
Adult Weight Screening and Followup
CQM: Alternate Core Set for
EPs
NQF Measure Number &
Clinical Quality Measure Title
PQRI Implementation Number
NQF 0024
Weight Assessment and Counseling
for Children and Adolescents
NQF 0041
PQRI 110
Preventive Care and Screening:
Influenza Immunization for Patients
50 Years Old or Older
NQF 0038
Childhood Immunization Status
CQM: Additional Set for EPs
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Diabetes: Hemoglobin A1c Poor Control
Diabetes: Low Density Lipoprotein (LDL) Management and Control
Diabetes: Blood Pressure Management
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker
(ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial
Infarction (MI)
Pneumonia Vaccination Status for Older Adults
Breast Cancer Screening
Colorectal Cancer Screening
Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Anti-depressant medication management: (a) Effective Acute Phase Treatment,(b)Effective
Continuation Phase Treatment
Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of
Severity of Retinopathy
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
Asthma Pharmacologic Therapy
Asthma Assessment
Appropriate Testing for Children with Pharyngitis
Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/
Progesterone Receptor (ER/PR) Positive Breast Cancer
Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
CQM: Additional Set for EPs
(cont’d)
20. Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
21. Smoking and Tobacco Use Cessation, Medical assistance: a) Advising Smokers and Tobacco Users
to Quit, b) Discussing Smoking and Tobacco Use Cessation Medications, c) Discussing Smoking and
Tobacco Use Cessation Strategies
22. Diabetes: Eye Exam
23. Diabetes: Urine Screening
24. Diabetes: Foot Exam
25. Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol
26. Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation
27. Ischemic Vascular Disease (IVD): Blood Pressure Management
28. Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
29. Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: a) Initiation, b)
Engagement
30. Prenatal Care: Screening for Human Immunodeficiency Virus (HIV)
31. Prenatal Care: Anti-D Immune Globulin
32. Controlling High Blood Pressure
33. Cervical Cancer Screening
34. Chlamydia Screening for Women
35. Use of Appropriate Medications for Asthma
36. Low Back Pain: Use of Imaging Studies
37. Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control
38. Diabetes: Hemoglobin A1c Control (<8.0%)
CQM: Eligible Hospitals and
CAHs
1. Emergency Department Throughput – admitted patients Median time from
ED arrival to ED departure for admitted patients
2. Emergency Department Throughput – admitted patients – Admission
decision time to ED departure time for admitted patients
3. Ischemic stroke – Discharge on anti-thrombotics
4. Ischemic stroke – Anticoagulation for A-fib/flutter
5. Ischemic stroke – Thrombolytic therapy for patients arriving within 2 hours of
symptom onset
6. Ischemic or hemorrhagic stroke – Antithrombotic therapy by day 2
7. Ischemic stroke – Discharge on statins
8. Ischemic or hemorrhagic stroke – Stroke education
9. Ischemic or hemorrhagic stroke – Rehabilitation assessment
10. VTE prophylaxis within 24 hours of arrival
11. Intensive Care Unit VTE prophylaxis
12. Anticoagulation overlap therapy
13. Platelet monitoring on unfractionated heparin
14. VTE discharge instructions
15. Incidence of potentially preventable VTE
Participation in HITECH and other
Medicare Incentive Programs for EPs
Other Medicare Incentive Program
Eligible for HITECH EHR Incentive
Program?
Medicare Physician Quality Reporting
Initiative (PQRI)
Yes, if the EP is eligible.
Medicare Electronic Health Record
Demonstration (EHR Demo)
Yes, if the EP is eligible.
Medicare Care Management
Performance Demonstration (MCMP)
Yes, if the practice is eligible. The MCMP
demo will end before EHR incentive
payments are available.
Electronic Prescribing (eRx) Incentive
Program
If the EP chooses to practice in the
Medicare EHR Incentive Program, they
cannot participate in the Medicare eRx
Incentive Program simultaneously in the
same program year. If the EP chooses to
participate in the Medicaid EHR
Incentive Program, they can participate
in the Medicare eRx Incentive Program
simultaneously.
EHR Incentive Program
Timeline
•
•
•
•
•
•
•
•
•
**Statutory
Registration for the EHR Incentive Programs will begin in January 2011
For Medicare providers, attestation for the EHR Incentive Programs will
begin in April 2011
EHR incentive payments will begin a month following the start of
attestations
For Medicaid providers, States may launch their programs in January 2011
and thereafter
November 30, 2011 – Last day for eligible hospitals and CAHs to register
and attest to receive an incentive payment for FFY 2011 (Medicare
providers)
February 29, 2012 – Last day for EPs to register and attest to receive an
incentive payment for CY 2011 (Medicare providers)
2015 – Medicare payment adjustments begin for EPs and eligible hospitals
that are not meaningful users of EHR technology**
2016 – Last year to receive a Medicare EHR incentive payment; Last year
to initiate participation in Medicaid EHR Incentive Program**
2021 – Last year to receive Medicaid EHR incentive payment**
Questions Regarding the
Regulation
• CMS website
http://www.cms.gov/EHRIncentivePrograms
• CMS subject matter experts will be working with
ONC and the states to do webinars and other
information sessions to help answer questions
• CMS will develop FAQs to respond to various
questions and provide toolkits and other materials
to assist providers
• CMS will issue additional guidance on how to
register and attest to meaningful use
• Requirements in the regulation can only be
modified through further rulemaking
So, what are we to do next?
Internal approach to Readiness Assessment
Leadership
Top CEO Issues
• The American College of Healthcare Executives’ annual
survey asked CEOs to identify their top three issues
Issue
Financial challenges
Percentage
responding
76%
Healthcare reform implications*
53
Care for the uninsured
37
Patient safety and quality
32
Governmental mandates
30
Physician-hospital relations
25
Patient satisfaction
15
Personnel shortages
13
Capacity
7
Technology
7
Governance*
2
Disaster preparedness
1
Issues about not-for-profit status
1
Source: American College of Healthcare Executives
*New issues added for 2009
Project Management Methodology
Challenges
• Political
– Champions
– Supportive environment
• Organizational
– Governance
– Shared goals and
objectives
– Operating rules
• Financial
– Access to capital
– Sustainable model
• Technical
– Integration with legacy
systems
– Security and privacy
– Data management
Self-Assessment
• Who should we be aligned with to move
our vision, mission and values forward?
• Where can we best contribute to the
improvement efforts, quality, care and
safety?
• What are the timelines and milestones to
which our organization must strive to
achieve meaningful use?
• How will our organization differentiate
in the market place?
Clinical IT Adoption Process
Planning
Design
Implementation
Training
Go-Live Support /
Improvement
Clinical IT Adoption
• Have your organizational goals and expected
results for the clinical IT project been identified in
the planning stage?
– Speed Bump: A project that has not involved both the
executive leadership and clinicians in setting a vision is
initially set up as just another IT project
• Is your organization designing the system from
the clinician perspective?
– Speed Bump: It is well documented that attempts to
implement a system by excluding clinicians in the design
phase can lead to resentment, lack of confidence in the
organization and counter-productive behaviors that
will challenge the success of the project
Clinical IT Adoption (cont.)
• Have you incorporated a formalized project charter
into your implementation process, identifying
challenges and overcoming obstacles?
– Speed Bump: Without a formalized process it is difficult
for clinicians to recognize that the clinical implementation
project represents a true commitment to success
• What is your training approach; do you have
different models for different roles in your
organization?
– Speed Bump: Physicians have rigorous time restraints;
therefore the lack of adequate staff and planning for oneon-one physician training will decrease
willingness for physicians to adopt the system
Clinical IT Adoption (cont.)
• Have you built in adequate time and resources
for your Go-Live and Support phase with the
clinicians’ day-to-day routine in mind?
– Speed Bump: Clinician buy-in will dramatically drop at
this juncture if the process does not adequately sustain
clinician use with day-to-day support and incorporate
feedback to further improve the system, producing
greater benefits for the clinician, the organization and
the patients
Next Steps in the Journey
Towards Meaningful Use
Linear View of MU Assessment
Assessment Matrix
• Technology Platforms and Applications Review
• Capital Budget Planning and Prioritization
• IT Staffing Plan Review
• Physician Alignment Summary
• On-Site Interview Notes
• Other Operational Considerations
• Privacy and Security Overview
• HIE
Other Considerations
• Calculate ARRA Incentives
• Define IT Projects in Relation to MU grid
• Complete GAP Analysis
• Prioritize Capital and Operational
Investment
Important Areas of Focus
• Vendor Sustainability and Focus
• Patient Throughput and Clinical Integration
• Quality Reporting
• Capital Spending and Incentive
Reimbursements
Questions & Answers
Interactive Session
Thank You!
Kevin R. Burchill, Esq., FACHE
[email protected]